JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
Clinical trial NCT03796676 · COMPLETED
Trial details
- NCT number
- NCT03796676
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-18
- Primary completion
- 2020-04-08
- Enrollment
- 287
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.